Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	75.6	94.32	89.6	223.3	97.79
Short-Term Investments	-	150.5	108.89	113.3	120.51	122.05
Cash & Short-Term Investments	226.1	226.1	203.2	202.89	343.81	219.84
Cash Growth	8.86%	11.27%	0.15%	-40.99%	56.39%	15.31%
Accounts Receivable	-	7,512	7,046	8,648	7,499	5,552
Other Receivables	-	100	47.17	39.11	6.98	24.37
Receivables	-	7,619	7,095	8,691	7,506	5,577
Inventory	-	4,729	4,859	5,163	5,259	4,150
Other Current Assets	-	808.7	1,050	861.42	824.5	621.43
Total Current Assets	-	13,384	13,207	14,918	13,934	10,568
Property, Plant & Equipment	-	11,891	10,351	8,622	7,665	6,844
Long-Term Investments	-	224.1	199.74	187.99	194.8	173.01
Other Intangible Assets	-	71.5	368.24	243.34	1.53	2.55
Other Long-Term Assets	-	176.4	197.04	242.33	284.36	72.61
Total Assets	-	25,747	24,324	24,214	22,080	17,660
Accounts Payable	-	4,161	4,496	4,925	4,687	3,300
Accrued Expenses	-	42.9	71.78	91.65	76.77	171.92
Short-Term Debt	-	-	2,147	3,605	3,563	1,572
Current Portion of Long-Term Debt	-	3,282	723.83	412.96	435	396.08
Current Portion of Leases	-	11.8	9.5	19.92	25.97	27.97
Current Income Taxes Payable	-	-	11.81	42.33	-	-
Other Current Liabilities	-	871.2	495.39	397.13	612.7	485.77
Total Current Liabilities	-	8,370	7,955	9,495	9,401	5,954
Long-Term Debt	-	2,840	2,753	2,047	1,385	1,476
Long-Term Leases	-	16.5	9.14	4.03	18.79	35.8
Long-Term Unearned Revenue	-	1.6	1.7	1.7	1.7	1.7
Long-Term Deferred Tax Liabilities	-	782.3	757.07	709.68	724.31	771.34
Other Long-Term Liabilities	-	-0.04	-0	-	157.45	269.89
Total Liabilities	-	12,053	11,504	12,287	11,717	8,526
Common Stock	-	912.7	919.35	926	926	932
Retained Earnings	-	-	11,701	10,811	9,240	8,018
Comprehensive Income & Other	-	12,777	194.75	187.48	197.4	184.54
Total Common Equity	13,690	13,690	12,815	11,924	10,364	9,134
Minority Interest	-	3.44	4.06	2.33	-0.6	-0.17
Shareholders' Equity	13,693	13,693	12,820	11,927	10,363	9,134
Total Liabilities & Equity	-	25,747	24,324	24,214	22,080	17,660
Total Debt	6,151	6,151	5,643	6,089	5,428	3,508
Net Cash (Debt)	-5,925	-5,925	-5,440	-5,886	-5,084	-3,288
Net Cash Per Share	-64.77	-64.65	-59.17	-63.57	-54.91	-35.28
Filing Date Shares Outstanding	91.27	91.37	91.94	92.6	92.6	93.2
Total Common Shares Outstanding	91.27	91.37	91.94	92.6	92.6	93.2
Working Capital	-	5,014	5,252	5,423	4,533	4,614
Book Value Per Share	149.84	149.84	139.40	128.77	111.92	98.01
Tangible Book Value	13,619	13,619	12,447	11,681	10,362	9,132
Tangible Book Value Per Share	149.05	149.05	135.39	126.14	111.90	97.98
Land	-	-	937.67	937.67	934.6	649.81
Buildings	-	-	2,257	1,932	1,921	1,882
Machinery	-	-	10,633	9,122	8,792	8,383
Construction In Progress	-	-	2,252	1,868	767.37	192.57

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.